levetiracetam
Generic: levetiracetam
Labeler: b. braun medical inc.Drug Facts
Product Profile
Brand Name
levetiracetam
Generic Name
levetiracetam
Labeler
b. braun medical inc.
Dosage Form
INJECTION
Routes
Active Ingredients
levetiracetam 5 mg/mL
Manufacturer
Identifiers & Regulatory
Product NDC
0264-5009
Product ID
0264-5009_c37794a6-677a-4669-83c6-8fbff7ab24fd
Product Type
HUMAN PRESCRIPTION DRUG
Marketing Category
ANDA
Application Number
ANDA209705
Listing Expiration
2026-12-31
Marketing Start
2024-05-13
Pharmacologic Class
Physiologic Effect
Normalized Code Variants
Searchable formats for this product NDC code
Digits Only
02645009
Hyphenated Format
0264-5009
Supplemental Identifiers
RxCUI
UNII
NUI
Packaging Origin
Original Packager
Resolved Product View
Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.
Resolved Identity
Brand Name
levetiracetam (source: ndc)
Generic Name
levetiracetam (source: ndc)
Application Number
ANDA209705 (source: ndc)
Routes
source: ndc
Resolved Composition
Strengths
- 5 mg/mL
Packaging
- 24 CONTAINER in 1 CASE (0264-5009-90) / 100 mL in 1 CONTAINER
Packages (1)
Ingredients (1)
Linked Drug Pages (1)
Raw FDA Data
View complete raw FDA NDC JSON payload
{"route": ["INTRAVENOUS"], "spl_id": "c37794a6-677a-4669-83c6-8fbff7ab24fd", "openfda": {"nui": ["N0000008486"], "unii": ["44YRR34555"], "rxcui": ["1193358", "1193360", "1193362"], "spl_set_id": ["ad32ec2f-b4e0-4811-8ea1-7a4abdd5c0a6"], "pharm_class_pe": ["Decreased Central Nervous System Disorganized Electrical Activity [PE]"], "manufacturer_name": ["B. Braun Medical Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "24 CONTAINER in 1 CASE (0264-5009-90) / 100 mL in 1 CONTAINER", "package_ndc": "0264-5009-90", "marketing_start_date": "20240513"}], "brand_name": "Levetiracetam", "product_id": "0264-5009_c37794a6-677a-4669-83c6-8fbff7ab24fd", "dosage_form": "INJECTION", "pharm_class": ["Decreased Central Nervous System Disorganized Electrical Activity [PE]"], "product_ndc": "0264-5009", "generic_name": "Levetiracetam", "labeler_name": "B. Braun Medical Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Levetiracetam", "active_ingredients": [{"name": "LEVETIRACETAM", "strength": "5 mg/mL"}], "application_number": "ANDA209705", "marketing_category": "ANDA", "marketing_start_date": "20240513", "listing_expiration_date": "20261231"}